Clinical Application of Quantitative MR Imaging in Nonalcoholic Fatty Liver Disease

Magn Reson Med Sci. 2023 Oct 1;22(4):435-445. doi: 10.2463/mrms.rev.2021-0152. Epub 2022 May 18.

Abstract

Viral hepatitis was previously the most common cause of chronic liver disease. However, in recent years, nonalcoholic fatty liver disease (NAFLD) cases have been increasing, especially in developed countries. NAFLD is histologically characterized by fat, fibrosis, and inflammation in the liver, eventually leading to cirrhosis and hepatocellular carcinoma. Although biopsy is the gold standard for the assessment of the liver parenchyma, quantitative evaluation methods, such as ultrasound, CT, and MRI, have been reported to have good diagnostic performances. The quantification of liver fat, fibrosis, and inflammation is expected to be clinically useful in terms of the prognosis, early intervention, and treatment response for the management of NAFLD. The aim of this review was to discuss the basics and prospects of MRI-based tissue quantifications of the liver, mainly focusing on proton density fat fraction for the quantification of fat deposition, MR elastography for the quantification of fibrosis, and multifrequency MR elastography for the evaluation of inflammation.

Keywords: fat; fibrosis; inflammation; magnetic resonance imaging; nonalcoholic fatty liver disease.

Publication types

  • Review

MeSH terms

  • Biopsy / adverse effects
  • Elasticity Imaging Techniques* / methods
  • Humans
  • Inflammation / complications
  • Inflammation / pathology
  • Liver / diagnostic imaging
  • Liver / pathology
  • Liver Cirrhosis / etiology
  • Liver Cirrhosis / pathology
  • Liver Neoplasms* / pathology
  • Magnetic Resonance Imaging / methods
  • Non-alcoholic Fatty Liver Disease* / complications
  • Non-alcoholic Fatty Liver Disease* / diagnostic imaging
  • Non-alcoholic Fatty Liver Disease* / pathology